March 16, 2015
Expanded medical isotope production part of Chalk River legacy - Tom Spears, Ottawa Citizen. When the Chalk River nuclear reactor is permanently shuttered, Canada will be in a much better position to provide medical isotopes than it was back in 2009. more
March 14, 2015
Untangling the web of European regulations for the preparation of unlicensed radiopharmaceuticals: a concise overview and practical guidance for a risk-based approach. Rogier Langea, Rob ter Heinea, Clemens Decristoforoe, Iván Peñuelasf, Philip H. Elsingab, Monique M.L. van der Westerlakena and N. Harry Hendriksec,d. read more
March 12-13, 2015
Health Canada's 2015 Regulatory Workshop on Radiopharmaceuticals
Please note the content of all the talks will be available in the Members section once the authors permission is given.
March 09, 2015
Call for abstracts - The Isotope Production Symposium (one of many sessions of interest) that will be held at the Pacific Basin Conference (Pacifichem) in Honolulu, Hawaii in December, 2015 (www.pacifichem.org ).
Please consider submitting an abstract (due April 3rd), and/or let your potentially interested colleagues, collaborators, students and post docs know about this symposium and encourage them to consider submitting an abstract. Click here for the flier.
Information concerning submission may be found at http://www.pacifichem.org/congress-details/abstracts/.
Please note that this request to submit does not guarantee that your contributed abstract will be accepted for inclusion in the symposium. Acceptance will depend upon the quality, significance and relevance of the work described in the abstract.
February 06, 2015
Government of Canada Announces Extension of National Research Universal (NRU) Reactor
OTTAWA, Feb. 6, 2015 /CNW/ - The Honourable Greg Rickford, Canada's Minister of Natural Resources, today announced the Government of Canada's decision to support the extension of the operations of the National Research Universal (NRU) reactor from October 31, 2016, until March 31, 2018. The NRU is operated by Canadian Nuclear Laboratories Ltd. (CNL), a subsidiary of Atomic Energy of Canada Limited.
Today's announcement of the extension of the NRU is designed to help support global medical isotope demand between 2016 and 2018 in the unexpected circumstances of shortages, and Canadian Nuclear Laboratories will now begin decommissioning the NRU after March 31, 2018. read more
Introducing the Canadian College of Radiopharmaceutical Scientists
As an initiative of the Canadian Association of Radiopharmaceutical Scientists a taskforce has been established to develop a plan for certification of radiopharmaceutical practitioners. Certification is initially to be voluntary, and upon successful adoption of the process by stakeholders, mandatory certification will be pursued.
Goals of certification include: setting and maintaining standards for the radiopharmaceutical sciences, providing a career structure for radiopharmaceutical scientists, promoting awareness of radiopharmaceutical science as a career choice, and facilitating movement nationally. read more